TCT 183: Multi-state Modeling of Tricuspid Regurgitation Disease Progression Rate using an EHR-integrated Natural Language Processing Platform
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Edwards Lifesciences; Boston Scientific Corporation